Please provide your email address to receive an email when new articles are posted on . Triple combination therapy with bempedoic acid, ezetimibe and atorvastatin significantly reduced LDL among ...

- Combining three orally administered once-daily LDL-C lowering medicines has not been previously studied, though combination therapy is common in other areas of cardiovascular medicine1 - - Results ...

Parsippany, N.J. (December 27, 2001) -- WelChol® (colesevelam HCl) and Lipitor® (atorvastatin calcium), taken in combination, can lower LDL cholesterol levels by 48% in patients with moderately high ...

More than a quarter of Americans over 40 take medications to lower their cholesterol, most of them statins. But not everyone can tolerate statins or wants to. Now a new study confirms that bempedoic ...

Merck and Schering-Plough Corporation to Develop Combo Pill with Lipitor WHITEHOUSE STATION, N.J. -- Merck & Co., Inc. announced today an agreement to commence development of an ezetimibe and ...

Lower baseline low-density lipoprotein cholesterol levels are linked to a higher risk for incident type 2 diabetes, largely ...

Combination of Lipitor® and Celecoxib at lower doses is most effective at limiting colon cancer developmentAnaheim, Calif. -- Combinations of Lipitor® and Celebrex® (celecoxib) at lower doses proved ...

Lokelma (sodium zirconium cyclosilicate) is a brand-name powder that’s prescribed for high potassium levels. Lokelma has interactions with other drugs and supplements. Examples include furosemide ...

- Results of bempedoic acid, ezetimibe and atorvastatin triple therapy study published in March issue of Atherosclerosis - - Combining three orally administered once-daily LDL-C lowering medicines has ...